astrazeneca

AstraZeneca signs license agreement with China’s CSPC worth up to $2bn

The agreement includes an upfront payment of $100m with the aim to strengthen the UK firm's cardiovascular portfolio.

October 09, 2024

Deals ramp up in Asia’s healthcare space with cancer focus

An acquisition in Hong Kong by the New Frontier Group, an IPO by Sunho Biologics on the HKEX and a $1.5bn investment into Singapore by AstraZeneca, are signs that investments in next generation cancer treatments are increasing in the region.

May 28, 2024

AstraZeneca invests $1.5bn in Singapore facility for next-generation cancer drugs

The manufacturing facility, supported by Singapore's Economic Development Board, is for antibody drug conjugates, and will be designed to be "zero carbon" from its first day of operation in 2029.

May 21, 2024

Treasury appointments, May 4

A roundup of the latest CFO and treasurer moves from around the region.

May 03, 2010